In vitro of cefotaxime against cephalothin-resistant clinical isolates.
作者信息
Van Landuyt H W, Pyckavet M
出版信息
Antimicrob Agents Chemother. 1979 Jul;16(1):109-11. doi: 10.1128/AAC.16.1.109.
Abstract
Cefotaxime is more active than six other cephalosporins against 150 cephalothin-resistant Enterobacteriaceae strains and is the only drug which is more active than ampicillin against Haemophilus. It shows a potentially useful activity against Pseudomonas.
摘要
相似文献
1
In vitro of cefotaxime against cephalothin-resistant clinical isolates.
Antimicrob Agents Chemother. 1979 Jul;16(1):109-11. doi: 10.1128/AAC.16.1.109.
2
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
Antimicrob Agents Chemother. 1980 Apr;17(4):743-9. doi: 10.1128/AAC.17.4.743.
3
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
Antimicrob Agents Chemother. 1980 May;17(5):807-12. doi: 10.1128/AAC.17.5.807.
4
[Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Boll Ist Sieroter Milan. 1982;61(4):309-19.
5
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
Am J Clin Pathol. 1979 Nov;72(5):858-60. doi: 10.1093/ajcp/72.5.858.
6
Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
Antimicrob Agents Chemother. 1976 Jun;9(6):1066-9. doi: 10.1128/AAC.9.6.1066.
7
In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
Antimicrob Agents Chemother. 1976 Jun;9(6):994-9. doi: 10.1128/AAC.9.6.994.
8
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
J Antibiot (Tokyo). 1977 Jul;30(7):576-82. doi: 10.7164/antibiotics.30.576.
9
10
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Antimicrob Agents Chemother. 1980 Jun;17(6):937-42. doi: 10.1128/AAC.17.6.937.
引用本文的文献
1
The cephalosporins: activity and clinical use.
Drugs. 1980 Aug;20(2):137-54. doi: 10.2165/00003495-198020020-00007.
2
Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application.
Graefes Arch Clin Exp Ophthalmol. 1983;220(5):245-7. doi: 10.1007/BF02308083.
3
Clinical efficacy of cefotaxime in serious infections.
Antimicrob Agents Chemother. 1982 Jan;21(1):119-24. doi: 10.1128/AAC.21.1.119.
4
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Antimicrob Agents Chemother. 1981 Oct;20(4):539-41. doi: 10.1128/AAC.20.4.539.
5
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
Antimicrob Agents Chemother. 1981 Dec;20(6):747-59. doi: 10.1128/AAC.20.6.747.
6
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Antimicrob Agents Chemother. 1980 Mar;17(3):516-7. doi: 10.1128/AAC.17.3.516.
7
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Antimicrob Agents Chemother. 1980 Mar;17(3):488-93. doi: 10.1128/AAC.17.3.488.
8
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
Antimicrob Agents Chemother. 1980 Jul;18(1):88-93. doi: 10.1128/AAC.18.1.88.
9
In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
Antimicrob Agents Chemother. 1980 Jul;18(1):1-8. doi: 10.1128/AAC.18.1.1.
10
Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
Antimicrob Agents Chemother. 1990 Nov;34(11):2047-9. doi: 10.1128/AAC.34.11.2047.
本文引用的文献
1
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
Antimicrob Agents Chemother. 1974 Jan;5(1):25-32. doi: 10.1128/AAC.5.1.25.
2
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
Antimicrob Agents Chemother. 1973 Jun;3(6):657-61. doi: 10.1128/AAC.3.6.657.
3
Haemophilus influenzae type B resistant to ampicillin. A report of two cases.
JAMA. 1974 Jul 15;229(3):298-301.
4
Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.
Am J Med. 1974 Aug;57(2):225-38. doi: 10.1016/0002-9343(74)90447-1.
5
Cefuroxime, a new cephalosporin antibiotic: activity in vitro.
Antimicrob Agents Chemother. 1976 Mar;9(3):511-9. doi: 10.1128/AAC.9.3.511.
6
Susceptibility of anaerobes to cefoxitin and other cephalosporins.
Antimicrob Agents Chemother. 1975 Feb;7(2):128-32. doi: 10.1128/AAC.7.2.128.
7
Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
Antimicrob Agents Chemother. 1976 Oct;10(4):657-63. doi: 10.1128/AAC.10.4.657.
8
In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
Antimicrob Agents Chemother. 1976 Jun;9(6):994-9. doi: 10.1128/AAC.9.6.994.
9
Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
Infection. 1977;5(4):259-60. doi: 10.1007/BF01640793.
10
Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.
J Antimicrob Chemother. 1978 Sep;4(5):445-50. doi: 10.1093/jac/4.5.445.
Zotero 插件